Evidence map›Paper›PMID 36522168›Full record

ArticleGenome research

Redistribution of lamina-associated domains reshapes binding of pioneer factor FOXA2 in development of nonalcoholic fatty liver disease.

Xiaolong Wei, Megan A Murphy, Nihal A Reddy, Yi Hao, Taylor G Eggertsen, Jeffrey J Saucerman, Irina M Bochkis

Open access · bronzeAbstract read
In one paragraph

Article in Genome research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Sequential ChIP-Seq.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Xiaolong WeiDepartment of Pharmacology, University of Virginia, Charlottesville, Virginia 22908, USA.
Megan A MurphyDepartment of Pharmacology, University of Virginia, Charlottesville, Virginia 22908, USA.
Nihal A ReddyDepartment of Pharmacology, University of Virginia, Charlottesville, Virginia 22908, USA.
Yi HaoDepartment of Pharmacology, University of Virginia, Charlottesville, Virginia 22908, USA.
Taylor G EggertsenDepartment of Biomedical Engineering, University of Virginia, Charlottesville, Virginia 22908, USA.
Jeffrey J SaucermanDepartment of Biomedical Engineering, University of Virginia, Charlottesville, Virginia 22908, USA.
Irina M BochkisDepartment of Pharmacology, University of Virginia, Charlottesville, Virginia 22908, USA.ORCID 0000-0001-8073-8408
University of Virginia · US

Funding

BASIC CARDIOVASCULAR RESEARCH TRAINING GRANTT32HL007284 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Brant E Isakson, Gary K Owens · 1985 to 2026
$19.6M
Role of Foxa2 in ligand-dependent activation of nuclear receptorsR01DK121059 · NIDDK · UNIVERSITY OF VIRGINIA · PI BOCHKIS, IRINA · 2020 to 2024
$2.0M
Virtual drug screen reveals context-dependent inhibition of cardiomyocyte hypertrophyF31HL168849 · NHLBI · UNIVERSITY OF VIRGINIA · PI EGGERTSEN, TAYLOR · 2023 to 2024
$44k
NHLBI NIH HHS F31 HL168849NHLBI NIH HHS T32 HL007284NIDDK NIH HHS R01 DK121059
6 · The paper itself

Abstract

Nonalcoholic fatty liver disease (NAFLD) is highly prevalent in type 2 diabetes mellitus and the elderly, impacting 40% of individuals over 70. Regulation of heterochromatin at the nuclear lamina has been associated with aging and age-dependent metabolic changes. We previously showed that changes at the lamina in aged hepatocytes and laminopathy models lead to redistribution of lamina-associated domains (LADs), opening of repressed chromatin, and up-regulation of genes regulating lipid synthesis and storage, culminating in fatty liver. Here, we test the hypothesis that change in the expression of lamina-associated proteins and nuclear shape leads to redistribution of LADs, followed by altered binding of pioneer factor FOXA2 and by up-regulation of lipid synthesis and storage, culminating in steatosis in younger NAFLD patients (aged 21-51). Changes in nuclear morphology alter LAD partitioning and reduced lamin B1 signal correlate with increased FOXA2 binding before severe steatosis in young mice placed on a western diet. Nuclear shape is also changed in younger NAFLD patients. LADs are redistrubted and lamin B1 signal decreases similarly in mild and severe steatosis. In contrast, FOXA2 binding is similar in normal and NAFLD patients with moderate steatosis and is repositioned only in NAFLD patients with more severe lipid accumulation. Hence, changes at the nuclear lamina reshape FOXA2 binding with progression of the disease. Our results suggest a role for nuclear lamina in etiology of NAFLD, irrespective of aging, with potential for improved stratification of patients and novel treatments aimed at restoring nuclear lamina function.

Indexed as

Diabetes Mellitus, Type 2Non-alcoholic Fatty Liver DiseaseAnimalsChromatinHepatocyte Nuclear Factor 3-betaHepatocytesLipidsLiverMiceChromatinFoxa2 protein, mouseHepatocyte Nuclear Factor 3-betaLipids

Identifiers

PMID36522168
PMCPMC9808618
OpenAlexW4311552930

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.